Logo image of 0QF.DE

MODERNA INC (0QF.DE) Stock Price, Quote, News and Overview

FRA:0QF - Deutsche Boerse Ag - US60770K1079 - Common Stock - Currency: EUR

23.61  -3.16 (-11.8%)

0QF.DE Quote, Performance and Key Statistics

MODERNA INC

FRA:0QF (8/1/2025, 7:00:00 PM)

23.61

-3.16 (-11.8%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High83.09
52 Week Low20.59
Market Cap9.13B
Shares386.74M
Float358.59M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)11-05 2025-11-05/bmo
IPO12-07 2018-12-07


0QF.DE short term performance overview.The bars show the price performance of 0QF.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

0QF.DE long term performance overview.The bars show the price performance of 0QF.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of 0QF.DE is 23.61 EUR. In the past month the price decreased by -9.28%. In the past year, price decreased by -70.98%.

MODERNA INC / 0QF Daily stock chart

0QF.DE Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 18.13 297.46B
AMG.DE AMGEN INC 14.03 137.28B
GIS.DE GILEAD SCIENCES INC 14.32 120.95B
VX1.DE VERTEX PHARMACEUTICALS INC N/A 101.91B
1REGN.MI REGENERON PHARMACEUTICALS 12.18 52.62B
ARGX.BR ARGENX SE 77.07 35.75B
22UA.DE BIONTECH SE-ADR N/A 22.13B
1BIIB.MI BIOGEN INC 8.12 16.66B
IDP.DE BIOGEN INC 7.78 16.01B
1MRNA.MI MODERNA INC N/A 9.13B
ABVX.PA ABIVAX SA N/A 4.60B
1VKTX.MI VIKING THERAPEUTICS INC N/A 3.31B

About 0QF.DE

Company Profile

0QF logo image Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Cambridge, Massachusetts and currently employs 5,800 full-time employees. The company went IPO on 2018-12-07. The firm is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). The company is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).

Company Info

MODERNA INC

325 Binney Street

Cambridge MASSACHUSETTS US

Employees: 5800

0QF Company Website

0QF Investor Relations

Phone: 16177146500

MODERNA INC / 0QF.DE FAQ

What is the stock price of MODERNA INC today?

The current stock price of 0QF.DE is 23.61 EUR. The price decreased by -11.8% in the last trading session.


What is the ticker symbol for MODERNA INC stock?

The exchange symbol of MODERNA INC is 0QF and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is 0QF.DE stock listed?

0QF.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for MODERNA INC stock?

31 analysts have analysed 0QF.DE and the average price target is 41.48 EUR. This implies a price increase of 75.68% is expected in the next year compared to the current price of 23.61. Check the MODERNA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MODERNA INC worth?

MODERNA INC (0QF.DE) has a market capitalization of 9.13B EUR. This makes 0QF.DE a Mid Cap stock.


How many employees does MODERNA INC have?

MODERNA INC (0QF.DE) currently has 5800 employees.


What are the support and resistance levels for MODERNA INC (0QF.DE) stock?

MODERNA INC (0QF.DE) has a support level at 22.71 and a resistance level at 29.04. Check the full technical report for a detailed analysis of 0QF.DE support and resistance levels.


Is MODERNA INC (0QF.DE) expected to grow?

The Revenue of MODERNA INC (0QF.DE) is expected to decline by -35.36% in the next year. Check the estimates tab for more information on the 0QF.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy MODERNA INC (0QF.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MODERNA INC (0QF.DE) stock pay dividends?

0QF.DE does not pay a dividend.


When does MODERNA INC (0QF.DE) report earnings?

MODERNA INC (0QF.DE) will report earnings on 2025-11-05, before the market open.


What is the Price/Earnings (PE) ratio of MODERNA INC (0QF.DE)?

MODERNA INC (0QF.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.6).


0QF.DE Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to 0QF.DE. When comparing the yearly performance of all stocks, 0QF.DE is a bad performer in the overall market: 97.58% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

0QF.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to 0QF.DE. While 0QF.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

0QF.DE Financial Highlights

Over the last trailing twelve months 0QF.DE reported a non-GAAP Earnings per Share(EPS) of -6.6. The EPS increased by 51.04% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -26.42%
ROE -33.35%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%36.04%
Sales Q2Q%-41.08%
EPS 1Y (TTM)51.04%
Revenue 1Y (TTM)-52.75%

0QF.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 56% to 0QF.DE. The Buy consensus is the average rating of analysts ratings from 31 analysts.

For the next year, analysts expect an EPS growth of -11.41% and a revenue growth -35.36% for 0QF.DE


Ownership
Inst Owners73.88%
Ins Owners2.56%
Short Float %N/A
Short RatioN/A
Analysts
Analysts56.13
Price Target41.48 (75.69%)
EPS Next Y-11.41%
Revenue Next Year-35.36%